Eagle Pharmaceuticals
EGRX
#11126
Rank
S$4.24 M
Marketcap
S$0.32
Share price
0.00%
Change (1 day)
-80.17%
Change (1 year)

Eagle Pharmaceuticals (EGRX) - Total liabilities

Total liabilities on the balance sheet as of June 2023 : S$0.19 Billion

According to Eagle Pharmaceuticals 's latest financial reports the company's total liabilities are S$0.19 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eagle Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$0.23 B121.48%
2021-12-31S$0.10 B17.55%
2020-12-31S$88.87 M-12.55%
2019-12-31S$0.10 B-4.44%
2018-12-31S$0.10 B-12.55%
2017-12-31S$0.12 B33.16%
2016-12-31S$91.31 M88.42%
2015-12-31S$48.46 M
2014-09-30S$25.92 M28.67%
2013-09-30S$20.14 M-23.89%
2012-09-30S$26.46 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
S$149.51 B 75,757.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$102.67 B 51,990.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$139.07 B 70,458.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$108.30 B 54,848.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$84.32 B 42,685.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$91.27 B 46,206.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$41.41 B 20,910.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel